Marie-Francoise Schulz-Aellen

Associate Director at Debiopharm International Sa

Marie-Francoise Schulz-Aellen's Professional Contact Details

Email (Verified)

****@debiopharm.com

Get Email Address

+41 21 321 01 11

Location

Lausanne, Vaud, Switzerland

Company

Debiopharm International Sa

Person Seniority

director

Marie-Francoise Schulz-Aellen's Current Company Details

Debiopharm International Sa

Lausanne, Vaud, Switzerland • 143 Employees

pharmaceuticals

Debiopharm Group (Debiopharm)is a Swiss-headquartered global biopharmaceutical group including five companies active in the life science areas of drug development, GMP manufacturing of proprietary drugs, diagnostic tools and investment management. Debiopharm International SA is focused on the development of prescription drugs that target unmet medical needs. The company in-licenses and develops promising drug candidates. The products are commercialized by pharmaceutical out-licensing partners to give access to the largest number of patients worldwide. Debiopharm independently funds the worldwide development of all of its products while providing expertise in pre-clinical and clinical trials, manufacturing, drug delivery and formulation, and regulatory affairs. Some of the key features of the group are: - a total financial independence & the stability of its top management - a wide set of internal competences completed by an extended network of external consultants - A comprehensive and worldwide partnering expertise Debiopharm completed the development and licensed out 5 products: EloxatinÂ®/ElplatÂ®/DacotinÂ®/DacplatÂ®, DecapeptylÂ®/TrelstarÂ®/PamorelinÂ® 1 month, 3 months and 6 months, and MoaparÂ®/SalcacylÂ®. If you have interesting molecules and seek a competent and committed partner to develop them, please contact us.

Founded Year

1979

Organization Website

debiopharm.com

Organization Languages

English

Organization Revenue

75000

Current Technologies

openssl

google analytics

youtube